Literature DB >> 9675660

Endoscopic treatment of a case of obstructive jaundice secondary to portal cavernoma.

L Solmi1, A Rossi, R Conigliaro, R Sassatelli, L Gandolfi.   

Abstract

Biliary changes secondary to portal hypertension are uncommon. These patients do not usually present clinical or biochemical evidence of cholestasis. This report describes one case of obstructive jaundice due to portal cavernoma. The obstructive jaundice appeared in adulthood in a patient who had developed the portal cavernoma during childhood. Endoscopic retrograde cholangiography allowed both the diagnosis and the palliative treatment of the stenosis of the common bile duct, avoiding risky surgical treatment.

Entities:  

Mesh:

Year:  1998        PMID: 9675660

Source DB:  PubMed          Journal:  Ital J Gastroenterol Hepatol        ISSN: 1125-8055


  6 in total

1.  Biliary cryptococcosis in a child: MR imaging findings.

Authors:  Chandan Jyoti Das; Ghan Shyam Pangtey; Smriti Hari; Pankaj Hari; Anup Kumar Das
Journal:  Pediatr Radiol       Date:  2006-06-07

Review 2.  Portal hypertensive biliopathy.

Authors:  Radha K Dhiman; Arunanshu Behera; Yogesh K Chawla; Jang B Dilawari; Sudha Suri
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

Review 3.  Portal biliopathy.

Authors:  Somnath Chattopadhyay; Samiran Nundy
Journal:  World J Gastroenterol       Date:  2012-11-21       Impact factor: 5.742

Review 4.  Endoscopic management of portal cavernoma cholangiopathy: practice, principles and strategy.

Authors:  Vivek A Saraswat; Praveer Rai; Tarun Kumar; Samir Mohindra; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2013-10-22

5.  Portal biliopathy: a study of 39 surgically treated patients.

Authors:  Anil Kumar Agarwal; Dharamanjai Sharma; Shivendra Singh; Shaleen Agarwal; S P Girish
Journal:  HPB (Oxford)       Date:  2011-01       Impact factor: 3.647

Review 6.  Therapeutic approaches for portal biliopathy: A systematic review.

Authors:  Irene Franceschet; Alberto Zanetto; Alberto Ferrarese; Patrizia Burra; Marco Senzolo
Journal:  World J Gastroenterol       Date:  2016-12-07       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.